KalVista Pharmaceuticals, Inc. (KALV) Operating Lease, Payments USD 2019 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
KalVista Pharmaceuticals, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2022.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending July 31, 2019 was $175 K.
  • KalVista Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.62 M, a 25.5% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.29 M, a 84.9% increase from 2020.
  • KalVista Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $696 K, a 1.7% decline from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.62 M +$328 K +25.5% May 1, 2022 Apr 30, 2023 10-K 2023-07-10
2021 $1.29 M +$591 K +84.9% May 1, 2021 Apr 30, 2022 10-K 2023-07-10
2020 $696 K -$12 K -1.7% May 1, 2020 Apr 30, 2021 10-K 2022-07-07
2019 $708 K May 1, 2019 Apr 30, 2020 10-K 2021-07-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.